Synthetic Biologics, Inc. (SYN)

SG&A Expense Growth

108.86%

Fiscal year · Period ending:

SYN logo

SYN SG&A Expense Growth

Latest reported108.86%
SYN FY SG&A Growth (YoY) (0.00% → 108.86%)
High-resolution chart · PNG

SYN sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Synthetic Biologics, Inc. SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
108.8561%
0%
52.2706%
28.7333%
9.8035%
-20.0279%
-23.3025%
-26.3827%
25.6255%
34.2757%
3.1036%
16.3607%
93.6631%
-4.1819%
4.6621%
-3.5504%
-29.7841%
164.8038%
403.6811%
0%
-100%
-1.5257%
61.5476%
23.7315%
-24.0955%
-34.7826%
-40.2597%
156.6667%
-53.125%
77.7778%
2,017.6471%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.